Skip to content

A randomized Controlled trial of the Case management to Encourage participation in cancer Screening for people with Schizophrenia in psychiatric outpatient clinics

A randomized Controlled trial of the Case management to Encourage participation in cancer Screening for people with Schizophrenia in psychiatric outpatient clinics - ACCESS

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036017
Enrollment
172
Registered
2019-06-01
Start date
2019-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia (including Schizoaffective disorder)

Interventions

Intervention group Case management to encourage participation in cancer screening will be implemented. Usual cancer screening promotion conducted in community setting by Okayama city will be imple

Sponsors

Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Outpatients diagnosed with schizophrenia or schizoaffective disorder according to the DSM-5 criteria by their primary psychiatrist 2) Patients who visited the hospital of the study site twice or more in the last 6 months 3) Patients aged 40 years or more 4) Patients who live in Okayama city and who are enrolled in the National Health Insurance or Public Assistance systems 5) Patients who understand and agree with the enrollment of this study with IC form, or patients whose proxies consents to their participation in the study

Exclusion criteria

Exclusion criteria: 1) Patients with a history of colorectal cancer 2) Patients who have already participated in colorectal cancer screening in the 2018 fiscal year 3) Patients who plan to move out of Okayama city within 6 months 4) Patients who lived in an institution where residents are supported for receiving cancer screenings 5) Patients who are judged by their primary psychiatrists as having a risk to deteriorate their symptoms by participating the study 6) Patients who are judged as having insufficient ability to judge by their primary psychiatrist, and who are not accompanied by their proxies in visiting clinics

Design outcomes

Primary

MeasureTime frame
The proportion of the participants who received municipal colorectal cancer screening in the fiscal year 2019

Secondary

MeasureTime frame
The proportion of the participants who received other municipal cancer screenings in the fiscal year 2019 which are recommended for participants Reasons of participation or non-participation in colorectal cancer screening and detailed examination recommended after screening Participant's comments on receiving the intervention and useful elements of the intervention Case manager's comments on useful elements and practical issues of the intervention Required time for the intervention

Countries

Japan

Contacts

Public ContactMasaki Fujiwara

Okayama University Hospital Department of Neuropsychiatry

mfujiwara@okayama-u.ac.jp086-235-7246

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026